Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors

BACKGROUND: Atherosclerotic cardiovascular diseases are the leading cause of death in the United States. A reduction in cholesterol with 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statin) significantly reduces mortality and morbidity. Statins may be associated with cognitive impairment or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Med Res
Main Authors: Roy, Satyajeet, Weinstock, Joshua Louis, Ishino, Allyse Sachiko, Benites, Jefferson Felix, Pop, Samantha Rachel, Perez, Christopher David, Gumbs, Edvard Adrian, Rosenbaum, Jennifer Ann, Roccato, Mary Kate, Shah, Hely, Contino, Gabriela, Hunter, Krystal
Formato: Artigo
Idioma:Inglês
Publicado em: Elmer Press 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5458663/
https://ncbi.nlm.nih.gov/pubmed/28611866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3066w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados